Axon (AXON) Valuation Check After a 23% Pullback From Its Multi‑Year Run

Simply Wall St

Axon Enterprise (AXON) has quietly pulled back over the past month, with the stock down about 23% after a strong multi year run. This raises the question of whether this is healthy consolidation or something more.

See our latest analysis for Axon Enterprise.

That pullback sits in sharp contrast to Axon’s powerful multi year run, where the 5 year total shareholder return is up 333.18% and even the 3 year total shareholder return is a hefty 216.55%. This suggests momentum is cooling, but the long term story remains very much intact.

If Axon’s ride has you rethinking where growth could come from next, it might be worth exploring high growth tech and AI stocks as potential new ideas for your watchlist.

With the share price well below analyst targets but still reflecting years of rapid growth, investors now face a key question: is Axon undervalued after this pullback, or is the market already pricing in its future expansion?

Most Popular Narrative: 33.9% Undervalued

With Axon closing at $543.55 versus a most popular narrative fair value of $822.50, the valuation gap hinges on aggressive growth and premium multiples.

Analysts are assuming Axon Enterprise's revenue will grow by 24.3% annually over the next 3 years.

Analysts assume that profit margins will shrink from 13.6% today to 10.4% in 3 years time.

Read the complete narrative.

Want to see why slower margins can still support a soaring valuation? The narrative leans on powerful revenue compounding and a daring future earnings multiple. Curious which assumptions really carry this price?

Result: Fair Value of $822.50 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, renewed regulatory scrutiny or slower government spending could quickly cool growth expectations and challenge the premium multiple that this narrative relies on.

Find out about the key risks to this Axon Enterprise narrative.

Another Lens on Valuation

Our SWS DCF model paints a more cautious picture, with Axon’s fair value at $383.06 versus the current $543.55. On this view, the stock looks overvalued, not undervalued. This raises a tougher question: are growth hopes running ahead of what cash flows can realistically deliver?

Look into how the SWS DCF model arrives at its fair value.

AXON Discounted Cash Flow as at Dec 2025

Build Your Own Axon Enterprise Narrative

If you prefer to dig into the numbers yourself and challenge these assumptions, you can build a custom Axon view in minutes: Do it your way.

A great starting point for your Axon Enterprise research is our analysis highlighting 2 key rewards and 3 important warning signs that could impact your investment decision.

Ready for your next investing move?

Do not stop at Axon. Use the Simply Wall St screener to quickly uncover fresh, data driven opportunities that could sharpen your edge before others notice.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Valuation is complex, but we're here to simplify it.

Discover if Axon Enterprise might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com